The Human Cost of War: A Looming Mental Health Crisis

The ongoing conflicts in Israel are casting a long shadow, not only in terms of physical casualties but also in the escalating mental health crisis among its soldiers. The Ministry of Defense recently revealed alarming figures: approximately 16,000 soldiers have already sustained injuries in the current war, and projections estimate that nearly 100,000 will suffer injuries by 2030, considering all of IsraelS military engagements. This paints a stark picture of the immense strain on the nation’s defense forces and the urgent need for complete support systems.

Adding to the concern, a critically important portion of veterans are grappling with psychological distress. At a recent international conference hosted by Israel, the Ministry reported that half of the soldiers involved in treaties have experienced psychological anguish. This highlights the profound emotional toll of combat and the potential for long-term mental health challenges.

The Lingering Scars of Past Conflicts

The impact of previous wars continues to resonate within the veteran community. Among 11,000 soldiers who have reported emotional difficulties stemming from past conflicts, approximately 70% identify emotional symptoms as their primary concern. This underscores the enduring nature of trauma and the importance of providing sustained mental healthcare services to veterans long after their active service.

Pride and Pressure: The IDF‘s Balancing Act

The Israel Defense Forces (IDF) has expressed pride in its ability to return a significant percentage of soldiers with war-related injuries,both physical and emotional,back to the battlefield. The IDF claims that 85% of soldiers with a mix of physical and emotional damage can return to combat. Moreover,the army has significantly increased the number of mental health providers within its ranks. Though, this emphasis on rapid reintegration has raised concerns among experts and anecdotal reports.

Is the atmosphere between these therapists and battle commanders really conducive to handling problems such as posttraumatic stress disorder (PTSD) properly, or if there is undue pressure by key officials to send to the soldiers back to combat even if they are only stable?

Questions are being raised about whether the pressure to return soldiers to combat readiness might be overshadowing the need for thorough and individualized mental healthcare, particularly in cases of post-traumatic stress disorder (PTSD). The delicate balance between military objectives and the well-being of soldiers is under scrutiny.

PTSD: An Existing Crisis Exacerbated

PTSD was already a significant concern before the current conflict, and the situation has only intensified since its onset. The scale of the October 7th attacks, described as a “fundamental and horrendous” disaster, has seemingly compelled a more accelerated approach to PTSD treatment within the military system.

Prior to the war, army psychologists faced resistance from high-ranking IDF officials and the Ministry of Defense in securing adequate funding, resources, and support for PTSD treatment. This reluctance has reportedly diminished in the wake of the October 7th events, signaling a potential shift in priorities.

Emerging Treatments: A Glimmer of Hope?

While traditional PTSD treatments often have limitations,a relatively new approach known as Stellate ganglion block (SGB) is gaining attention. According to Stella Global, a company promoting its use, SGB addresses “the root cause of anxiety, depression, PTSD, and prolonged COVID symptoms.”

When addressing the biological source, these treatments can provide innovative relief where traditional methods may have failed.
Stella’s website

Stella Israel, a subsidiary of Stella Global, has been offering SGB treatments in Tel Aviv and Haifa hospitals since 2022. The company’s general manager, Jason Blankfield, and medical director, Jason Cohen, recently stated that the IDF’s 669 rescue unit was engaged in battle situations for an extended period, exposing soldiers to frequent traumatic events.

The Promise of Innovation

If Stella’s SGB treatment can deliver on its promise of providing novel relief for PTSD, it would be a welcome development, given the immense challenges facing Israel’s military personnel. The need for effective and accessible mental healthcare solutions has never been more critical.

The Hidden Scars of Conflict: PTSD in israeli Soldiers

While physical injuries sustained in combat are readily apparent, the psychological toll on soldiers, particularly the risk of Post-Traumatic Stress Disorder (PTSD), frequently enough remains a hidden and underestimated outcome of military service.The term “emotional damage” can often mask the severity of the challenges these individuals face, which extend far beyond simple depression.

The urgency of addressing this issue is underscored by alarming statistics. While precise figures are challenging to obtain, anecdotal evidence suggests a concerning rise in mental health crises among soldiers, particularly since recent escalations in conflict. Many observers express concern that the full extent of the problem is being downplayed to avoid discouraging potential recruits.

Beyond the tragic instances of suicide, a significant number of soldiers struggle to reintegrate into civilian life, facing profound difficulties in resuming normal functioning. The challenges are compounded by limited access to timely and effective treatment.

Struggles with Access to Care

Reports from medical professionals at Shaarei Tzedek indicate that they are seeing several soldiers each week presenting with significant emotional distress. A major obstacle is that many of these soldiers are not officially classified as terror victims, which restricts their access to subsidized therapies. This lack of support raises concerns that their conditions will become chronic, significantly diminishing their chances of a full recovery.

Stella and the Stellate Ganglion Block (SGB): A New Approach to Trauma treatment

Recognizing the limitations of traditional approaches, organizations like Stella are pioneering innovative treatments for PTSD. Stella officials emphasize a shift from viewing psychological care as an isolated intervention to a more integrated and biologically informed approach. This new understanding is based on investigations, including those conducted at the Walter Reed Medical Center in the United States.

The old model was the psychological care model as something independent. Now there is a new understanding about how we can perhaps treat trauma, including based on investigations at the Walter Reed Medical Center in the United States.

stella Officials

The core of Stella’s approach involves identifying biological markers in blood samples to tailor treatment plans to individual needs. This targeted approach aims to move away from a trial-and-error methodology, where professionals previously had to resort to a spaghetti against the wall approach, hoping something would stick.

How SGB Works and Its Potential Benefits

Stella is actively working to raise awareness about the availability of SGB treatment. They have secured funding to provide treatment, initially free for survivors of the Nova festival, while working to integrate it into the broader healthcare system. Currently, reservists pay a subsidized rate of approximately 750 NIS per treatment, with many patients receiving further discounts based on their individual circumstances.

The Stellate Ganglion Block (SGB) is emerging as a promising intervention. According to Stella officials, SGB offers significant advantages, particularly its rapid action and the limited number of treatments required.

SGB is not only the best available treatment,but has enormous advantages when required only two treatments. What do you have to lose? They are only two one -hour sessions more than the trip to the treatment center and has a clinical success rate of 75%.

Stella Officials

Clinical data supports these claims. A recent study of 150 patients in Israel showed a significant reduction in PCL scores (a standard measure of PTSD symptom severity) following SGB treatment, decreasing from an average of 51 to 33, indicating a ample improvement in symptoms.

Addressing the Limitations of Traditional therapies

Traditional talk therapy, while valuable, often has limitations in its reach and duration. While victims of the Nova festival received 30 free psychological treatments from the government,they were then left to navigate their recovery on their own.

Cannabis as a PTSD Treatment: A Word of Caution

While acknowledging that cannabis can provide relief from sleep deprivation, a common symptom of PTSD, Stella officials caution against its unrestricted use. They highlight the risk of individuals transitioning from medical use to recreational use, potentially leading to excessive consumption and other complications.

The Speed of Recovery: A Critical Factor

The rapid onset of symptom relief with SGB is a significant advantage, particularly for patients experiencing acute distress. Stella officials emphasize that SGB can produce noticeable improvements within hours or days, contrasting with the months of consistent sessions required for traditional therapy or the 4-6 weeks needed for pharmacological interventions to show effectiveness.

Early intervention is crucial in trauma recovery. Prompt and effective treatment can significantly alter the trajectory of PTSD, preventing it from becoming a chronic and debilitating condition.

Revolutionizing PTSD Treatment: the Rise of Stellate ganglion Block (SGB)

Post-traumatic stress disorder (PTSD) affects millions worldwide, with the World Health Association estimating that approximately 3.6% of the global population experiences the condition annually.Traditional treatments,including psychotherapy and pharmacotherapy,often present challenges such as side effects,limited efficacy,and high dropout rates. However, a novel approach known as Stellate Ganglion Block (SGB) is gaining traction as a potentially transformative intervention.

Understanding SGB: A Targeted Approach to PTSD Relief

SGB involves injecting a local anesthetic into the stellate ganglion, a cluster of nerves in the neck. Proponents suggest this procedure directly modulates the sympathetic nervous system, a key physiological component implicated in PTSD. By calming overstimulated bodily organs, SGB aims to restore functionality and alleviate the debilitating symptoms of PTSD.

SGB directly modulates the hyperactive sympathetic nervous system, a key physiological component of PTSD.This approach avoids the broader systemic effects of medications and subjective challenges of verbal therapy.

SGB vs. Traditional Therapies: A Comparative Analysis

Unlike traditional therapies that indirectly address symptoms through cognitive restructuring or neurotransmitter modulation, SGB targets the root cause of autonomic dysregulation.This direct approach may offer a more complete and effective restoration of system functionality.

consider the limitations of conventional methods:

• Pharmacotherapy: Often associated with side effects like weight gain, sexual dysfunction, sedation, and the risk of dependency, particularly with benzodiazepines.
• Psychotherapy: While non-invasive, can initially exacerbate symptoms as patients confront traumatic memories.

SGB presents a potentially safer alternative, with localized and temporary side effects and no systemic pharmacological impact, reducing the risks associated with medication interactions or dependence.

Enhanced Treatment Adherence and Complementary Benefits

SGB offers prolonged symptom relief with just two treatments, reducing the burden of continuous therapy. This contrasts with traditional therapies that require sustained commitment and frequently enough face high abandonment rates due to logistical, financial, or emotional barriers.

Moreover, SGB can complement existing treatments by reducing hyperactivity, allowing patients to engage more effectively in therapeutic interventions and minimizing reliance on medication.

SGB Approval and Current Status

While SGB has gained approval in some regions, its adoption varies. In Israel, the Ministry of Defense has approved SGB for subsidized treatment. The Walter Reed Medical Center is conducting research to potentially establish SGB as a first-line treatment for PTSD.

The United States Veterans Association currently classifies SGB as a second-line treatment, citing the need for more extensive research on long-term effectiveness and diverse populations.however, there is growing evidence supporting SGB’s efficacy in relieving chronic pain, particularly in those with complex regional pain syndrome (CRPS).

A look at SGB’s History

SGB treatment has been available in Israel since mid-2022, with over 700 individuals receiving the procedure. Notably, 80% of these treatments occurred within the past year, indicating a growing acceptance and utilization of SGB as a viable option for PTSD management.

A Beacon of Light: SGB Therapy Gains Traction worldwide

In the wake of increasing global unrest and trauma, a medical procedure known as Stellate Ganglion Block (SGB) is emerging as a promising treatment for trauma-related conditions. Originally developed from research pioneered by Dr.Eugene Lipov, who published initial findings in 2008, SGB is now being sought after by individuals across the globe, offering a potential path to recovery for those grappling with the psychological scars of conflict and disaster.

Global Demand for SGB Treatment Soars

The demand for SGB treatment has seen a significant uptick, particularly in regions affected by conflict and crisis. while the treatment schedule typically involves three to five sessions per month during the initial year, some months have seen a dramatic surge in demand.As a notable exmaple,one clinic reported administering 50 treatments in both September and January,highlighting the urgent need for mental health support in response to triggering events.

Treatment Availability: A patchwork Across Nations

While SGB treatment is gaining acceptance, its availability varies significantly across different countries.In the United States, approximately 8,000 individuals received SGB treatment in 2023-2024, with over 6,000 of those treatments occurring in the last year alone. Australia has also embraced the therapy, with around 600 people treated. Though, England has yet to approve the treatment, leading some British citizens to seek it out in countries like Israel.

Citizens from Ukraine, the Czech Republic, and other nations have also traveled to Israel to access SGB therapy, underscoring the global demand and the willingness of individuals to cross borders in search of relief.

The Science Behind the Block: How SGB Works

SGB involves injecting a local anesthetic into the stellate ganglion, a cluster of nerves in the neck. This block can help to “reset” the nervous system, potentially alleviating symptoms of post-traumatic stress disorder (PTSD), anxiety, and other trauma-related conditions. While the exact mechanisms are still being studied, research suggests that SGB can reduce the “fight or flight” response and promote a sense of calm.

According to the National Center for PTSD, an estimated 6% of the U.S. population will experience PTSD at some point in their lives. With global events contributing to increased trauma exposure, the need for effective treatments like SGB is more critical than ever.

Overcoming Bureaucratic Hurdles and Restoring Hope

The journey from initial discovery to widespread treatment has been a long one. Dr. Lipov’s initial research laid the groundwork, but translating those findings into a publicly available treatment program required navigating complex bureaucratic processes and securing necessary approvals.

Many psychiatrists have lost hope after October 7, and we hope to return some light to this field.
Blankfield and Cohen, SGB treatment providers

As SGB treatment continues to gain recognition and acceptance, it offers a renewed sense of hope for individuals struggling with the debilitating effects of trauma. The ongoing research and increasing availability of SGB represent a significant step forward in the field of mental health care.